
Palantir Technologies (PLTR) shares have declined for five consecutive sessions, falling 6.7% on Tuesday and now down 14% from their all-time high, despite still being up 115% in 2025. This downturn, alongside drops in other AI stocks like Nvidia and CoreWeave, signals a potential rotation out of highly valued AI plays, a sentiment echoed by UBS. Short seller Andrew Left of Citron Research is actively betting against PLTR, citing its "lofty valuation" and questioning its comparable defensibility and multiple relative to private OpenAI, arguing that even at a significantly lower price, Palantir would remain expensive given its current commercial revenue trajectory. This broader market movement reflects growing investor anxiety regarding AI's impact on traditional software licensing models and overall market positioning.
Palantir Technologies (PLTR) is experiencing a significant correction, with shares falling 6.7% in a single session to extend a five-day losing streak, placing the stock 14% below its recent all-time high. This decline is not isolated, but part of a broader rotation out of high-valuation AI stocks, as evidenced by concurrent drops in Nvidia (NVDA), CoreWeave (CRWV), and the tech-software ETF (IGV). The sell-off is amplified by a pointed short-seller campaign from Citron Research, which argues that Palantir's valuation is unjustifiably lofty. Citron's analysis posits that even if PLTR traded at the same 17x price-to-2026-revenue multiple as a private leader like OpenAI, it would imply a stock price of 40—a level Citron still considers expensive for a SaaS company—questioning Palantir's defensibility and fundamentals. While Palantir's year-to-date gain of 115% was fueled by retail enthusiasm for AI and speculation on winning government contracts, the article notes that its commercial revenue has not yet substantially increased. This sentiment is echoed by UBS, which, despite long-term conviction in AI, recommends a more balanced near-term positioning across the AI value chain. Despite the sharp pullback, Palantir maintains a strong Relative Strength Rating of 98 and a positive B+ Accumulation/Distribution Rating, suggesting some institutional support remains, though technically the stock must now form a new base before a clear buy point emerges.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
moderately negative
Sentiment Score
-0.40
Ticker Sentiment